Saturday, October 19, 2024
HomeBusinessThe global asthma and COPD drug market is expected to grow at...

The global asthma and COPD drug market is expected to grow at a CAGR of 3.9% during the forecasting period 2023-2030

Asthma and COPD Drug Market Overview

Global asthma and COPD drug market growth is driven by the increase in the incidence and prevalence of asthma and COPD, technological advancements, and a growing geriatric population. Asthma is a non-communicable, chronic inflammatory lung disorder of the airways. Airways hyper-responsiveness leads to recurrent episodes of wheezing, breathlessness, chest tightness, and cough. Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation that is not fully reversible.

Asthma and COPD Drug Market Dynamics

The asthma and COPD drug market is growing rapidly, driven by the development of new and innovative drugs, such as itepekimab, and the increasing prevalence of these diseases. However, the market faces some challenges, including strict government regulations and side effects associated with drugs.

For More Insights Download Sample

Technological advancements are anticipated to drive the growth of the market in the forecast period. Limitations of traditional treatments, such as the late onset of action and low efficacy, are projected to encourage the development of novel targeted drugs, thereby driving the market.

Asthma and COPD Drug Market Segment Analysis

By Diseases

  • Asthma
  • COPD

By Spectrum

  • Combination Drugs
  • Inhaled Corticosteroids (ICS)
  • Short-Acting Beta Agonists (SABA)
  • Long-Acting Beta Agonists (LABA)
  •  Leukotriene Antagonists (LTA)
  • Anticholinergics
  • Others

By Distribution Channel

  • Online Pharmacy
  • Retail Pharmacy
  • Others
  • Hospital Pharmacy

By Region

  • North America
  • South America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Major Companies Covered

AstraZeneca PLC, Boehringer Ingelheim GmbH, GlaxoSmithKline PLC, Novartis AG, Hoffmann-La Roche Ltd, Pfizer Inc., Grifols SA, Merck & Co. Inc., Sanofi SA, Sumitomo Dainippon Pharma Co. Ltd

About us

DataM Intelligence 4 Market Research is a premier market research and business consulting firm that empowers businesses with accurate, reliable, and real-time market data and insights across a wide range of industries. Established in 2017, we have collaborated with over 750 companies, delivering valuable market intelligence for more than 6000 markets. Our expertise, extensive industry coverage, and robust research methodology have earned us the trust of our clients, making us their go-to partner for market intelligence needs.

At DataM Intelligence, we provide comprehensive, insightful, and actionable market intelligence, helping businesses navigate complex market landscapes and make informed decisions. Our dedicated team of analysts and industry experts possess in-depth knowledge and experience in their respective fields, ensuring the highest levels of accuracy and data integrity. Choose DataM Intelligence for all your market research and business consulting needs and experience the difference our commitment to excellence can make for your business.

Media Contact

Company Name: DataM Intelligence
Contact Person: Sonal Kumari
Email: info@datamintelligence.com
Phone:+1 877 441 4866
Country: United States
Website: https://www.datamintelligence.com/

RELATED ARTICLES

Most Popular

test test test

test test test

test test test

test test test